Tcrcure Biopharma Ltd.
Clinical trials sponsored by Tcrcure Biopharma Ltd., explained in plain language.
-
Experimental cell therapy targets Hard-to-Treat tumors
Disease control TerminatedThis early-stage study tested a new treatment called ALPP CAR-T cells in 5 people with advanced solid tumors that had stopped responding to standard therapies. The goal was to see if the treatment was safe and to find the best dose. The study was terminated early, so results are …
Phase: EARLY_PHASE1 • Sponsor: TCRCure Biopharma Ltd. • Aim: Disease control
Last updated May 26, 2026 10:23 UTC
-
Engineered immune cells take on HPV-driven cervical cancer
Disease control TerminatedThis early-phase trial tested a new cell therapy called TC-E202 for people with advanced cervical cancer that had stopped responding to standard treatments. The therapy uses a patient's own immune cells, modified to recognize and attack cancer cells infected with HPV16. The study…
Phase: PHASE1, PHASE2 • Sponsor: TCRCure Biopharma Ltd. • Aim: Disease control
Last updated May 22, 2026 13:50 UTC